Emmerin, France

Vanessa Legry

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Vanessa Legry

Introduction

Vanessa Legry is a prominent inventor based in Emmerin, France, recognized for her significant contributions to the field of pharmacology. With two patents to her name, she is making strides in the development of therapeutic combinations that have the potential to transform treatments for various medical conditions. Her work showcases a blend of innovation and scientific research, marking her as a notable figure in the industry.

Latest Patents

Legry's latest patents include the development of a combination involving a PPAR agonist, such as elafibranor, paired with an acetyl-CoA carboxylase (ACC) inhibitor. This invention relates to a combination product and its therapeutic applications. Additionally, she has patented a combination of elafibranor or its derivatives with an anti-NASH, anti-fibrotic, or anti-cholestatic agent, further emphasizing her dedication to advancing treatment options.

Career Highlights

Currently, Vanessa Legry is associated with Genfit, a leading company in the biopharmaceutical sector. Her role in this organization has enabled her to leverage her expertise and push forward innovative solutions in drug development. With a solid track record of inventions, she embodies the spirit of research and development, consistently contributing to the discovery of effective therapies.

Collaborations

Throughout her career, Legry has collaborated with esteemed colleagues such as Robert Walczak and Carole Belanger. These partnerships not only highlight her ability to work effectively within a team but also enhance the innovation process, leading to impactful contributions in her field.

Conclusion

Vanessa Legry stands out as a pioneering inventor whose patents are paving the way for advanced therapeutic strategies. Her work at Genfit, alongside talented collaborators, underscores the importance of innovation in addressing complex medical challenges. As she continues to expand her research and patent portfolio, Legry is sure to remain a key player in the realm of pharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…